Skip to the page

Data / Form D filings / FORE US Bio Inc.

FORE US Bio Inc.: Form D filings

FORE US Bio Inc., a biotechnology company in Philadelphia, PA, filed 3 Form D notices with the SEC between 2023 and 2026. The latest, on July 14, 2026, reports $70.4 million sold of a $109.6 million offering to 20 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3675 MARKET STREET SUITE 200, Philadelphia, PA, 19104
Phone
(267) 641-7575
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1990659

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 14, 2026Amendment$109,619,395$70,410,173$39,209,22220Apr 30, 2025sec.gov
May 15, 2025New notice$46,024,857$37,443,239$8,581,6189Apr 30, 2025sec.gov
Aug 24, 2023New notice$122,561,289$62,079,394$60,481,89520Aug 9, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
William HinshawExecutive Officer, Director
Erez ChimovitsDirector
Dieter WeinandDirector
Chandra LeoDirector
Rajeev DadooDirector
Giovanni MariggiDirector
Michael ByrnesExecutive OfficerChief Financial Officer
Kim BlackwellDirector

Other biotechnology companies in Pennsylvania that filed recently

Every Form D from the week of Jul 13, 2026 · All recent filings in Pennsylvania · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what FORE US Bio Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.